SA to roll out groundbreaking six-month HIV jab in April 2026
Zuko Komisa Lenacapavir vaccination drug syringe in yellow gloved hands. Medical concept South Africa plans to roll out lenacapavir, a revolutionary long-acting, six-monthly HIV prevention injection, as early as March 2026. The initiative is backed by R500 million in Global Fund financing and will target high-risk groups in key districts. Crucially, the annual cost has been reduced by over 700 times to just R690, offering a major opportunity to eliminate […]